Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib Study of Duvelisib (YHI-1702) in Relapsed or Refractory CLL/SLL
jRCT2080224791Phase 1Completed
- Sponsor
- Yakult Honsha
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of duvelisib in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by Yakult Honsha. Started Jul 2019; status: completed.
02
Drugs
duvelisib
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on jRCT2080224791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224791.